Qivalis Gets DNB EMI Licence for Euro Stablecoin Under MiCA
A euro-denominated stablecoin issued under European law and supervised by a European central bank is no longer a distant prospect. On 14 October 2026, Amsterdam-based banking consortium Qivalis announced that De Nederlandsche Bank (DNB) has granted it Electronic Money Institution (EMI) authorisation, clearing the primary licensing hurdle required to issue euro-denominated electronic money tokens under the EU's Markets in Crypto-Assets Regulation (MiCA). For accounting firms, auditors, and CFOs using crypto accounting software to manage digital asset positions, this development redraws the stablecoin compliance map in the eurozone.
What the DNB Authorisation Actually Means
EMI authorisation under Dutch law is not a light-touch registration. It places Qivalis under continuous prudential and conduct supervision by the DNB, the same central bank that oversees traditional payment institutions and banks operating in the Netherlands. The licence confirms that Qivalis has met capital adequacy, governance, safeguarding, and operational resilience requirements demanded of any entity that holds client funds in electronic form.
The link to MiCA's e-money token framework
Under MiCA, a euro-pegged stablecoin qualifies as an e-money token (EMT). Crucially, MiCA requires an EMT issuer to hold an EMI licence or a banking licence in at least one EU member state. The DNB authorisation therefore satisfies that gateway condition. Qivalis still needs to publish a MiCA-compliant white paper and fulfil any additional supervisory requirements before tokens are distributed, but the hard part, the licensing itself, is done. Issuance is planned for the coming months.
Ongoing supervisory obligations
Being supervised by the DNB carries recurring obligations: regular prudential reporting, reserve audits, AML programme maintenance under the EU's Anti-Money Laundering Directives, and adherence to MiCA's own conduct rules for EMT issuers. Any firm that holds, settles in, or custodies Qivalis tokens will need to verify those obligations are being met, because they flow downstream into counterparty due diligence.
Why a Euro Stablecoin Matters to the Market
The stablecoin market currently sits at roughly 303 billion US dollars in total capitalisation, with Tether's USDT alone accounting for more than 60 percent of that figure at approximately 183 billion dollars. The overwhelming majority of on-chain settlement today is denominated in US dollars. That creates a structural currency mismatch for eurozone businesses that want to use blockchain-based settlement: they incur FX risk and FX transaction costs every time they touch a dollar stablecoin.
Qivalis's strategic positioning
Qivalis describes itself as a European banking consortium and frames its euro stablecoin explicitly as an on-chain settlement asset issued under European law and subject to European regulatory standards. That framing is deliberate. By May 2026 the consortium had expanded to 37 banking institutions across 15 countries, giving the token a ready-made distribution network and a credible claim to institutional backing that most earlier euro stablecoin attempts have lacked.
Jan-Oliver Sell, CEO of Qivalis, stated: "We believe Europe should have a euro-denominated on-chain settlement asset issued under European law and subject to European regulatory standards." That positioning speaks directly to the regulatory gap highlighted in recent cross-border stablecoin analysis, and it aligns with the EU's broader push to assert monetary sovereignty in digital asset markets. You can read more about those systemic concerns in our coverage of how the FSB flags cross-border stablecoin risks in its global report.
Accounting Implications for Firms and CFOs
A MiCA-regulated euro EMT has a more predictable accounting treatment than an unregulated stablecoin, but it still demands careful classification and ongoing monitoring.
Classification under IFRS
Under IFRS 9, an e-money token is most likely classified as a financial asset. Because its value is contractually pegged to the euro and backed by a regulated reserve, it may qualify as a debt instrument measured at amortised cost or fair value through other comprehensive income, rather than at fair value through profit or loss. That matters for balance sheet volatility: firms holding a regulated euro EMT could avoid the mark-to-market swings that characterise unpegged crypto assets. However, the specific classification depends on whether the token passes the solely payments of principal and interest (SPPI) test, and that analysis must be done at the instrument level. Firms should not assume all stablecoins receive identical treatment.
Reserve and custody disclosure
MiCA mandates that EMT issuers hold reserves in segregated, high-quality liquid assets and publish reserve disclosures. For audit purposes, this creates a verifiable paper trail. Auditors can request DNB supervisory filings and the issuer's published reserve reports as part of asset existence and valuation procedures. This is a material improvement over the opaque reserve structures that have historically complicated digital asset audit work.
Functional currency and FX considerations
For eurozone entities whose functional currency is already the euro, holding a euro EMT eliminates the translation difference that arises when settling in USDT or USDC. Treasury teams and CFOs should factor this into their cash management policies: a euro EMT may be treated as near-cash depending on liquidity terms and redemption rights, which also affects how it is presented on the statement of financial position.
Practical workflow for crypto bookkeeping software
Firms relying on digital asset accounting software will need to ensure their systems can correctly tag Qivalis tokens with the right asset class, functional currency, and regulatory status once issuance begins. Incorrectly treating a euro EMT as an unregulated crypto asset would skew both the balance sheet classification and any regulatory capital calculations for firms subject to prudential rules. Now is the time to update chart-of-accounts configurations and transaction tagging rules before the token is live.
AML and KYC Obligations for Counterparties
The DNB licence and MiCA's EMT framework impose a structured AML regime on Qivalis itself. But firms that accept, hold, or transact in the token carry their own obligations.
Counterparty due diligence
Accepting a regulated EMT in payment or settlement does not extinguish a firm's own AML duties. Under the EU's AML Directives, obliged entities must still conduct customer due diligence and, where relevant, enhanced due diligence. Receiving a Qivalis token from a counterparty does not automatically make that counterparty lower-risk. Firms must still verify the source of funds and screen against sanctions lists.
Travel Rule compliance
MiCA's transfer of funds provisions, which align with the FATF Travel Rule, apply to EMT transfers. When Qivalis tokens move between regulated service providers, originator and beneficiary information must travel with the transaction. Compliance teams should check whether their existing Travel Rule solution covers the token's technical standard before onboarding it as a settlement asset. This connects to the broader supervisory architecture discussed in our analysis of how the EU Council limited ESMA crypto supervision to significant CASPs, which sets out which entities will face the most intensive regulatory scrutiny.
White paper review as a due diligence step
MiCA requires Qivalis to publish a white paper before token distribution. That document will set out the reserve composition, redemption rights, governance structure, and risk disclosures. Compliance officers at any firm considering using the token for settlement should treat that white paper as a mandatory pre-onboarding document, reading it with the same rigour applied to a fund prospectus.
What Accounting Firms Should Do Before Issuance
Qivalis has said issuance is planned for the coming months. That is a narrow window. Accounting firms advising eurozone clients on digital asset strategy, and CFOs who run treasury operations that already touch stablecoins, have a short lead time to get prepared.
Steps to take now
First, update your firm's stablecoin classification policy to carve out a category for MiCA-regulated euro EMTs, distinct from both unregulated crypto assets and traditional fiat balances. Second, review your digital asset accounting software and crypto bookkeeping software configurations to confirm they support euro-denominated EMT tagging and can generate the audit trail required for reserve verification. Third, brief your AML team on Travel Rule obligations specific to EMTs, because these differ in some respects from the obligations that apply to asset-referenced tokens. Fourth, watch for the Qivalis white paper publication, which will trigger the window for detailed due diligence. Fifth, consider whether any clients in sectors such as payments, trade finance, or treasury management have a near-term business case for euro-denominated on-chain settlement, so you can advise them proactively rather than reactively.
Frequently Asked Questions
What is an EMI licence and why does Qivalis need one?
An Electronic Money Institution licence authorises an entity to issue electronic money, which includes stablecoins pegged to a fiat currency under the MiCA framework. MiCA specifically requires euro-pegged stablecoins classified as e-money tokens to be issued by a licensed EMI or bank. Without this authorisation, Qivalis could not legally distribute its euro stablecoin in the EU.
How should a euro EMT be classified on a corporate balance sheet under IFRS?
Most likely as a financial asset under IFRS 9. The specific measurement category, amortised cost or fair value, depends on the instrument's contractual cash flow characteristics and the entity's business model. Because a euro EMT is pegged to fiat and backed by regulated reserves, it may pass the SPPI test, supporting an amortised cost classification. Each entity must perform its own assessment and document it.
Does holding a Qivalis token reduce a firm's AML obligations?
No. The fact that Qivalis is itself regulated by the DNB and subject to MiCA does not transfer its AML compliance to token holders. Firms remain independently obliged to conduct customer due diligence on counterparties, screen transactions, and comply with Travel Rule requirements when transferring the token between regulated service providers.
When will Qivalis actually issue the stablecoin?
Qivalis has indicated issuance is planned within the coming months, but the exact date depends on completing remaining MiCA requirements and publishing the mandatory white paper. Until the white paper is published, the token cannot be distributed to the public under MiCA rules.
Which firms are most directly affected by this development?
Accounting firms with eurozone digital asset clients, payment service providers, treasury teams at corporates already using stablecoins for settlement, auditors responsible for digital asset attestations, and any compliance function that will need to onboard the Qivalis token as a recognised asset class. Firms using crypto accounting software or digital asset accounting software should begin configuration reviews now.
Source: Cointelegraph